Laboratory Corporation of America Holdings (LH)

214.90 +1.57 (+0.74%) As of 09:48AM EDT. Market open.

Laboratory Corporation of America Holdings

358 South Main Street
Burlington, NC 27215
United States
336 229 1127
https://www.labcorp.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 75,000

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Adam H. Schechter	Pres, CEO & Chairman	5.51M	N/A	1965
Mr. Glenn A. Eisenberg	CFO & Exec. VP	2.3M	N/A	1961
Dr. Brian J. Caveney M.P.H., M.D., J.D., MPH	Exec. VP, Pres of Diagnostics & Chief Medical Officer	1.57M	N/A	1974
Mr. Mark S. Schroeder	Exec. VP and Pres of Diagnostics Laboratory Operations & Global Supply Chain	1.59M	N/A	1961
Dr. Paul R. Kirchgraber M.D.	Exec. VP and CEO of Early Devel., Central Laboratories & Global Oncology Bus.es	2.02M	N/A	1963
Dr. Michelle Abelson Ph.D.	Laboratory Director of Operations	N/A	N/A	N/A
Mr. Peter J. Wilkinson	Sr. VP & Chief Accounting Officer	N/A	N/A	1972
Mr. Lance V. Berberian	Exec. VP and Chief Information & Technology Officer	N/A	N/A	1963
Dr. Marcia T. Eisenberg Ph.D.	Chief Scientific Officer & Sr. VP	N/A	N/A	1960
Chas Cook	VP of Investor Relations	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Corporate governance

Laboratory Corporation of America Holdings’s ISS governance QualityScore as of 1 February 2023 is 1. The pillar scores are Audit: 3; Board: 6; Shareholder rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.